Puberty menorrhagia in modern era: analysis in a tertiary care centre

Prachi Saurabh Koranne, Aparna R. Wahane


Background: Puberty menorrhagia can pose a significant challenge to the gynecologist when associated with serious systemic complications like anaemia and hypoproteinaemia. Early diagnosis and treatment with individualization of each and every case is the keystone in the management of puberty menorrhagia. Exclusion of pregnancy is mandatory in every case, irrespective of the history, reassurance, counseling, regular follow-up along with a balanced nutritional diet and long term iron therapy go a long way in successful management of such cases.

Methods: Data was collected from medical case records in each of these cases from indoor case sheets.

Results: There were 35 indoor admissions in the gynaecology ward at GMC Akola 2011 to 2013 for critical puberty menorrhagia over a span of two years. The leading cause was anovulatory dysfunctional uterine bleeding. Other systemic associations included hypothyroidism, idiopathic thrombocytopenic purpura, genital tuberculosis, and PCOD. Each case was analyzed for demographic profile, duration of menorrhagia, severity of symptoms, degree of anaemia, final diagnosis, requirement of blood and component therapy and response to conservative management.  

Conclusions: Most abnormal bleeding in adolescents is caused by immaturity of the hypothalamic - pituitary ovarian axis resulting in anovulation. Approximately 20% of adolescents have an underlying endocrine or haematological disorder requiring targeted diagnostic testing.


Puberty menorrhagia, Bleeding disorders, Dysfunctional uterine bleeding, Hormonal therapy

Full Text:



Caufriez A. Menstrual disorders in adolescence: Pathophysiology and treatment. Horm Res. 1991;36:156.

Devore GR, Owens O, Kase N. Use of intravenous premarin in the treatment of dysfunctional uterine bleeding: a double blind randomized control study. Obstet Gynaecol. 1982;59:285.

Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000;(4):CD000249.

Davey DA. Dysfunctional Uterine Bleeding. In: C. R. Whitfield, eds. Dewhurst’s Textbook of Obstetrics and Gynaecology for Postgraduates. 5th ed. New York: Wiley, John & Sons; 1995: 591-607.

Royal College of Obstetricians and Gynaecologists. RCOG guideline for management of menorrhagia after referral to secondary care. In: RCOG, eds. National Evidence Based Clinical Guideline No 5. London: RCOG; 1999: 1-134.

Claessens EA, Cowell CA. Acute adolescent menorrhagia, Am J Obstet Gynaecol 1981;139:277.

Raj SG, Raj MH, Talbert LM, Sloan CS, Hicks B. Normalization of testosterone levels using a low estrogen containing oral contraceptive in women with polycystic ovary syndrome. Obstet Gynaecol 1983;60:15.

Korytkowski MT, Mokan M, Horwitz MJ, Berga SL. Metabolic effects of oral contraceptives in women with polycystic ovary syndrome. J Clin Endocrinal Metab. 1996;80:517.

Debra A, Minjarez MD, Karen D, Bradshaw MD. Abnormal uterine bleeding in adolescents. Obstet Gynaecol Clin North Am. 2000;27(1):63-8.

Dutta DC. Pelvic infections: genital tuberculosis. In: Dutta DC, eds. Textbook of Gynaecology. 2nd ed. Kolkata, India: New central book agency (P) Ltd; 1990: 128-134.

Robert I. Handin. Disorders of the platelet and vessel wall. Harrisons Principles of Internal Medicine. In: Eugene Braunwald, Anthony S. Fauci, Dennis L. Kasper, Stephen L. Hauser, Richard M. Stone, Dan L. Longo, J. Larry Jameson, eds. 15th ed. New York: McGraw-Hill Companies; 2001: 745-750.

Tripathi KD. Drugs affecting coagulation, bleeding and thrombosis. In: Tripathi KD, eds. Essentials of Medical Pharmacology. 4th ed. New Delhi, India: Jaypee Brothers Medical Publishers; 1999: 599.

Duflos-Cohade C, Amandruz M, Thibaud E. Pubertal menorrhagia. J Pediatr Adolesc Gynaecol. 1996;9:16.